We aim to distill and synthesize information from the literature about the roles of MIF and CD74 in cancer, to provide perspectives on these two molecules as predictive biomarkers for immune checkpoint therapy and to uncover gaps in knowledge and present them as future directions for research in the field. Here, CD74 is linked to cancer.